AFLD 2015 FFC vs Respondent M31

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M31 for a violation of the Anti-Doping Rules. During a cycling event on October 12, 2014, respondent delivered a sample for doping test purposes. Analysis of the sample showed the presence of prednisone and prednisolone which are prohibited substances according the World Anti-Doping Agency (WADA) 2014 prohibited list. They are regarded as specified substances.

History
The respondent had used medication containing prednisolone wich metabolizes in the body into prednisone. It was used for therapeutic reasons for a oncology treatment of his thorax. He had medical statements to prove his condition and medication. The measured concentration of the prohibited substance was in accordance with the doses on his prescription.

Decision
1. The respondent is acquitted.
2. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
7 May 2015
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Prednisolone
Prednisone
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
2 October 2015
Date of last modification
21 October 2015
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin